Welcome to our dedicated page for Schrodinger SEC filings (Ticker: SDGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Schrödinger, Inc. (SDGR) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, alongside AI-powered tools that help interpret key documents. As a Nasdaq-listed issuer, Schrödinger files current reports on Form 8-K, annual reports on Form 10-K and quarterly reports on Form 10-Q, among other documents, to provide transparency into its operations, governance and financial condition.
Recent Form 8-K filings illustrate the range of topics covered in SDGR’s regulatory reporting. The company has furnished press releases announcing quarterly financial results under Item 2.02, giving detail on software revenue, drug discovery revenue, software gross margin, operating expenses, cash position and non-GAAP measures. Other 8-K filings describe matters such as the submission of proposals to stockholders at the annual meeting, voting outcomes for director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
Schrödinger has also used Form 8-K to disclose executive compensation and separation arrangements under Item 5.02, including a separation and release of claims agreement with a former executive vice president and chief financial officer. These filings outline severance-related payments, equity vesting terms, COBRA-related benefits and other contractual provisions, providing insight into the company’s executive compensation framework.
On Stock Titan, users can review SDGR’s 10-K and 10-Q filings for detailed discussions of its software and drug discovery activities, risk factors, segment information and accounting policies. AI-powered summaries help explain lengthy filings by highlighting important sections, such as revenue breakdowns between software and drug discovery, non-GAAP reconciliations and disclosures related to collaborations and equity investments. The platform also surfaces Form 4 insider transaction reports, allowing users to track equity awards and share transactions by directors and officers.
With real-time updates from EDGAR and AI-generated overviews, the Schrödinger SEC filings page is intended to make it easier to navigate complex regulatory documents, compare periods and understand how SDGR’s computational platform, collaborations and therapeutics portfolio are reflected in its official disclosures.
Kenneth P. Lorton submitted a Form 144 reporting transactions in the issuer's common stock. The filing lists a proposed sale tied to restricted stock vesting on 03/04/2026 and discloses 925 shares sold on 02/10/2026 for $12,703.77.
SDGR Rule 144 notice: the filing lists 1,094 common shares designated "to be sold" following restricted stock vesting on 03/04/2026 and cites NASDAQ as the market. The broker of record is Fidelity Brokerage Services LLC.
The filing also records a separate sale by Yvonne K. Tran of 776 common shares on 02/10/2026.
Fidelity Brokerage Services LLC submitted a Form 144 notice reporting 775 common shares proposed for sale tied to restricted stock vesting. The filer also disclosed prior sales of 752 common shares on 02/10/2026 for $10,370.38.
SDGR reports a Form 144 notice for proposed sales of 3,661 shares of common stock tied to restricted stock vesting on 03/04/2026. The filing records 5,560 shares sold during the past three months and lists Fidelity Brokerage Services LLC as an agent on 03/05/2026.
SanDisk (SDGR) filing a Form 144 discloses proposed sales of common stock tied to a restricted stock vesting and a recent disposition by an associated person. The broker listed is Fidelity Brokerage Services LLC and the filing references NASDAQ.
The notice lists 1,366 shares from a restricted stock vesting reported on 03/04/2026 as securities to be sold by the issuer, and a separate reported sale of 2,206 shares by Karen O. Akinsanya-Akiwumi on 03/02/2026 with proceeds shown as $26,454.36. The Form date shown is 03/05/2026.
SDGR filed a Rule 144 notice to sell securities. The filing lists 3,125 shares of Common Stock to be sold as a stock bonus on 03/04/2026. It also records 1,230 shares sold on 02/09/2026. The document shows 64,500,510 shares outstanding as of 03/04/2026.
Schrodinger, Inc. director Richard Friesner exercised stock options that converted into 160,527 shares of common stock. The options, granted on May 11, 2016, were fully vested and were exercised at a price of $3.07 per share.
Following the transaction, Friesner directly owned 682,224 shares of Schrodinger common stock, which includes 5,997 unvested restricted stock units. He also had indirect ownership of 694,925 shares through the RF 2018 grantor retained annuity trust and 28,328 shares held by his spouse.
Schrodinger, Inc. director and President & CEO Farid Ramy reported a mix of equity awards and a small share sale. He received a stock option for 112,500 shares, vesting 25% on March 2, 2027 with the remainder vesting monthly through March 2, 2030, subject to continued service. He also received several grants and vesting events of common stock and performance-based restricted stock units, and now holds common stock that includes 142,009 unvested RSUs. On the same date, he sold 5,560 shares of common stock at a weighted average price of $11.8977 per share under a pre-arranged Rule 10b5-1 plan to cover withholding taxes from PRSU vesting, which the footnotes state was not a discretionary trade.
Schrödinger, Inc.’s EVP & CFO Rachit Jain received new equity awards. On March 2, 2026, he was granted stock options covering 34,250 shares of common stock at an exercise price of $0.0000 per share, increasing his option holdings to 34,250 shares.
He also received a grant of 17,130 restricted stock units (RSUs), each representing one share of common stock, bringing his common stock holdings to 54,227 shares, which includes 52,660 unvested RSUs. The RSUs vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030. The options vest 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, in each case subject to his continued service with the company.